By grafting of ADAM9 expressing B16F1 melanoma cells in animals carrying complete ablation of this protease, we could show that in vivo ablation of this protease in stromal fibroblasts leads to enhanced tumor growth as a result of altered cellular activities [15]. This evidence concerns the gene ADAM9 and neoplasm.